AdvaStim’s CTO Barry Yomtov to Present at Neurotech Investing & Partnering Conference
On April 23, AdvaStim’s Chief Technical Officer and co-founder, Barry Yomtov will present at the 9th Annual Neurotech Investing & Partnering Conference in Boston at the Ritz Carleton Hotel. This is the premier partnering and investing conference for the neurotechnology industry including pharmaceuticals, medical devices and diagnostics and will focus on Advances in Drugs, Devices and Diagnostics for the Brain and Nervous System. Read more here: https://www.regonline.com/builder/site/tab1.aspx?EventID=1246370
Barry will present at the session titled, New Developments in Chronic and Neuropathic Pain. The session will focus on drugs and devices with novel mechanisms of action and emerging treatment options that are on the horizon to decrease side effects and improve efficacy in chronic and neuropathic pain. Presenting along with AdvaStim will be executives from Autonomic Technologies, Soterix Medical, and Trigemina, moderated by Kiran Reddy, Associate Partner at Third Rock Ventures.
The Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.